MSTVIM
ABMD

Messner & Smith Theme Value Investment Management’s Abiomed Inc ABMD Stock Holding History

Messner & Smith Theme Value Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$1.35M Sell
4,656
-1,897
-29% -$481K 2.25% 18
2017
Q4 		$1.23M Sell
6,553
-4,095
-38% -$765K 1.96% 19
2017
Q3 		$1.8M Sell
10,648
-180
-2% -$27.2K 2.8% 11
2017
Q2 		$1.55M Sell
10,828
-355
-3% -$47.7K 2.7% 10
2017
Q1 		$1.4M Sell
11,183
-216
-2% -$25K 2.27% 19
2016
Q4 		$1.28M Sell
11,399
-11,813
-51% -$1.37M 2.1% 19
2016
Q3 		$2.98M Sell
23,212
-1,014
-4% -$121K 4.8% 1
2016
Q2 		$2.65M Sell
24,226
-342
-1% -$34K 4.88% 2
2016
Q1 		$2.33M Sell
24,568
-2,101
-8% -$177K 4.59% 3
2015
Q4 		$2.41M Sell
26,669
-104
-0.4% -$8.83K 3.85% 5
2015
Q3 		$2.48M Sell
26,773
-25,230
-49% -$2.22M 4.9% 6
2015
Q2 		$3.42M Sell
52,003
-997
-2% -$66.2K 4.7% 4
2015
Q1 		$3.79M Buy
53,000
+138
+0.3% +$7.49K 5.41% 2
2014
Q4 		$2.01M Sell
52,862
-401
-0.8% -$12.6K 3.41% 7
2014
Q3 		$1.32M Sell
53,263
-1,174
-2% -$29.7K 2.31% 20
2014
Q2 		$1.37M Sell
54,437
-6,180
-10% -$144K 2.16% 19
2014
Q1 		$1.42M Buy
60,617
+20,960
+53% +$580K 2.14% 19
2013
Q4 		$1.06M Buy
39,657
+180
+0.5% +$4.45K 2.31% 13
2013
Q3 		$752K Buy
39,477
+18,049
+84% +$413K 1.78% 23
2013
Q2 		$462K Buy
+21,428
New +$431K 1.07% 32

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Messner & Smith Theme Value Investment Management's ABMD Position: Q1 2018 in Review

Messner & Smith Theme Value Investment Management reduced its Abiomed Inc (ABMD) stake by 29% in Q1 2018, selling an estimated $481K and leaving 4,656 shares worth $1.35M. The position accounts for 2.25% of the portfolio, ranked #18.

Messner & Smith Theme Value Investment Management first reported a position in ABMD in Q2 2013 and has held it in 20 quarters since. The position peaked at $3.79M in Q1 2015. 405 funds tracked by Wall St. Rank hold ABMD as of Q1 2018.

  • Messner & Smith Theme Value Investment Management held 4,656 shares of Abiomed Inc worth $1.35M as of Q1 2018.
  • Messner & Smith Theme Value Investment Management sold 1,897 Abiomed Inc shares in Q1 2018, an estimated $481K.
  • Abiomed Inc made up 2.25% of Messner & Smith Theme Value Investment Management's portfolio in Q1 2018, its #18 holding.
  • Messner & Smith Theme Value Investment Management first reported a position in Abiomed Inc in Q2 2013 and has held it in 20 quarters since.
  • Messner & Smith Theme Value Investment Management's Abiomed Inc position peaked at $3.79M in Q1 2015.
  • 405 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2018.

Based on Messner & Smith Theme Value Investment Management's 13F filing for Q1 2018, filed 9 May 2018.